-
Making Health Data Trustees Sustainable: An Overview of Potential Business and Financing Models
Sep 9, 2025, 16:22 PM -
Prevalence Utilization Patterns and Economic Impact of eGFR and ALK-Targeted Therapies in Non-Small Cell Lung Cancer: A Nationwide Real-World Analysis From Greece
Sep 9, 2025, 16:22 PM -
The Use of Patient-Reported Experience Measures in Adults With Obstructive Sleep Apnea: A Systematic Evidence Review
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Tenecteplase vs. Alteplase for Adults With Acute Ischemic Stroke (AIS) in Greece
Sep 9, 2025, 16:22 PM -
Bridging the Gap Between AI Principles and Practice: A Comparative Evaluation of AI Position Statements and Frameworks for Responsible Use
Sep 9, 2025, 16:22 PM -
Dominance in Economic Evaluation as a Leverage in Pharmaceutical Price Negotiation
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Early Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer Alongside the LIBELULE Randomized Phase III Trial
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab for Patients With High-Risk Early Stage Triple-Negative Breast Cancer in Chile
Sep 9, 2025, 16:22 PM -
Indirect Costs Associated With Pneumococcal Disease: A Global Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Subcutaneous vs. Intravenous Administration in Oncology: A Literature Review of Impacts on Patients, Providers, and Hospitals
Sep 9, 2025, 16:22 PM -
Systematic Literature Review (SLR) of First-Line (1L) Treatments of Patients With Advanced or Metastatic HER2-Positive Gastroesophageal Adenocarcinoma (GEA)
Sep 9, 2025, 16:22 PM -
Assessing the Psychometric Performance of the Experimental EQ-TIPS V20 in Assessing the Health-Related Quality of Life of Stunted Children in Laos
Sep 9, 2025, 16:22 PM -
Patient-Centered PICO Scoping in EU HTA: A Pilot Study for Structured Consensus Building Using a Delphi Panel
Sep 9, 2025, 16:22 PM -
Impact of the Decline in the Number of Community Dermatologists in France on Treatment of Actinic Keratosis (EPIKA Study)
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of 68-Ga-PSMA-11 PET CT Imaging Followed by 177Lu-PSMA-617 Therapy in Metastatic Castrate-Resistant Prostate Cancer
Sep 9, 2025, 16:22 PM -
From Insight to Impact: Rethinking Pharma-Payer Partnerships to Enable Future Access in Europe
Sep 9, 2025, 16:22 PM -
Real-World Evidence (RWE) and Its Impact on Scottish Medicines Consortium (SMC) Decisions: A Retrospective Review
Sep 9, 2025, 16:22 PM -
Long-Term HTA Trends in Patient Organization Submissions to the NCPE and Future Perspectives
Sep 9, 2025, 16:22 PM -
Number of Inquiries for a Second Course of Teprotumumab in the US Over Four Years
Sep 9, 2025, 16:22 PM -
Enhancing Patient Engagement in Consensus Development: Global Insights From a Targeted Review of Digital Platforms and Methods
Sep 9, 2025, 16:22 PM
